SecBot SecBot
3 ·Filed Nov 12, 2026

TEVA

TEVA PHARMACEUTICAL INDUSTRIES LTD
NEUTRAL
Impact 2/10
Horizonimmediate Processed4d 6h ago SEC0001193125-26-458294
Form 3: initial insider ownership statement
Actionable Insight • Neutral

Monitor future Form 4 filings for any insider transactions by Brailer, which would signal his view of the stock. No immediate trading signal from this initial filing.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1
Entry
$44.50
T+0 close · Nov 12, 2026 · via day close
Latest settled
−4.34%
T+1 · $42.57
Vs SPY
−2.43%
α at T+1
Next horizon
T+5
in 3d
  1. T+0 · Nov 13 $44.50entry
  2. T+1 · 16h ago −4.34%α −2.43% · $42.57
  3. T+5 · in 3d Pending
  4. T+20 · in 27d Pending
  5. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

David J. Brailer filed a Form 3 initial statement of beneficial ownership upon becoming a non-executive director of Teva Pharmaceutical Industries. The filing includes a power of attorney authorizing officers to handle Section 16 reporting. No securities ownership amounts are disclosed in the filing.

Key Facts

  • David J. Brailer appointed as non-executive director of Teva Pharmaceutical Industries Ltd.
  • Form 3 filed on 2026-11-12 for period beginning 2026-11-03.
  • Power of attorney executed on 2026-10-26 authorizing Dov Bergwerk, Shira Aran-Porat, and Matan Kimchi to handle Section 16 filings.
  • No beneficial ownership amounts reported in the filing documents.

Financial Impact

No financial impact; routine director onboarding filing.

Risk Factors

  • No ownership data disclosed; cannot assess insider alignment.

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
3 Filing (Primary)0001193125-26-458294
Document: 0001193125-26-458294-index-headers.html0001193125-26-458294
Document: 0001193125-26-458294-index.html0001193125-26-458294
Document: 0001193125-26-458294.txt0001193125-26-458294

Track record

61 reports on TEVA

Performance horizon

6 of 8 bullish or bearish reports moved the stock their way by T+60. Best: +33.06% at T+60 after the Jul 20, 2026 report. 15 of 17 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $43.16 Now $42.57 −1.37% settles Feb 12
  2. Nov 12, 20264d ago 3 Neutral 2/10 Viewing Entry $44.50 Now $42.57 −4.34% settles Feb 11
  3. Nov 12, 20264d ago 144 Neutral 2/10 Entry $44.50 Now $42.57 −4.34% settles Feb 11
  4. Nov 12, 20264d ago 144 Neutral 2/10 Entry $43.65 Now $42.57 −2.47% settles Feb 10
  5. Nov 10, 20266d ago 144 Neutral 3/10 Entry $43.24 Now $42.57 −1.55% settles Feb 9
  6. Nov 10, 20266d ago SC 13G/A Neutral 3/10 Entry $42.40 Now $42.57 +0.40% settles Feb 8
  7. Nov 9, 20267d ago 144 Neutral 2/10 Entry $42.40 Now $42.57 +0.40% settles Feb 8
  8. Nov 6, 202610d ago Insider Cluster Neutral 3/10 Entry $42.97 Now $42.57 −0.93% settles Feb 5
  9. Nov 6, 202610d ago Insider Cluster Neutral 2/10 Entry $42.97 Now $42.57 −0.93% settles Feb 5
  10. Nov 5, 202611d ago 144 Neutral 2/10 Entry $42.61 Now $42.57 −0.09% settles Feb 4
Showing 10 of 61

US Market Status

Market Closed · Opens Wed (10h 47m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 12, 2026